Ekso Bionics Holdings Inc

NASDAQ:EKSO  
2.46
-0.04 (-1.60%)
Earnings Announcements

Ekso Bionics Reports Preliminary Q4 And Full Year 2021 Financial Results

Published: 01/10/2022 14:10 GMT
Ekso Bionics Holdings Inc (EKSO) - Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results.
Ekso Bionics Holdings Inc - Preliminary Total Revenue for Q4 of 2021 is an Estimated Range of $3.9 Million to $4.1 Million.
Revenue is expected to be $2.76 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $3.2 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.